✦ LIBER ✦

TET2 Mutations Improve the New European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study

✍ Scribed by Metzeler, K. H.; Maharry, K.; Radmacher, M. D.; Mrozek, K.; Margeson, D.; Becker, H.; Curfman, J.; Holland, K. B.; Schwind, S.; Whitman, S. P.; Wu, Y.-Z.; Blum, W.; Powell, B. L.; Carter, T. H.; Wetzler, M.; Moore, J. O.; Kolitz, J. E.; Baer, M. R.; Carroll, A. J.; Larson, R. A.; Caligiuri, M. A.; Marcucci, G.; Bloomfield, C. D.

Book ID: 118272763
Publisher: American Society of Clinical Oncology
Year: 2011
Tongue: English
Weight: 187 KB
Volume: 29
Category: Article
ISSN: 0732-183X
DOI: 10.1200/jco.2010.32.7742

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of a 24-Gene Prognostic S

Identification of a 24-Gene Prognostic Signature That Improves the European LeukemiaNet Risk Classification of Acute Myeloid Leukemia: An International Collaborative Study

✍ Li, Z.; Herold, T.; He, C.; Valk, P. J. M.; Chen, P.; Jurinovic, V.; Mansmann, U 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 658 KB

TET2 Mutations in Acute Myeloid Leukemia

TET2 Mutations in Acute Myeloid Leukemia (AML): Results From a Comprehensive Genetic and Clinical Analysis of the AML Study Group

✍ Gaidzik, V. I.; Paschka, P.; Spath, D.; Habdank, M.; Kohne, C.-H.; Germing, U.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 220 KB

Prognostic Impact of Isocitrate Dehydrog

Prognostic Impact of Isocitrate Dehydrogenase Enzyme Isoforms 1 and 2 Mutations in Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group

✍ Boissel, N.; Nibourel, O.; Renneville, A.; Gardin, C.; Reman, O.; Contentin, N.; 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 274 KB

Adult de novo acute myeloid leukemia wit

Adult de novo acute myeloid leukemia with t(6;11)(q27;q23) : Results from Cancer and Leukemia Group B study 8461 and review of the literature

✍ William Blum; Krzysztof Mrózek; Amy S. Ruppert; Andrew J. Carroll; Kathleen W. R 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

## Abstract ## BACKGROUND Acute myeloid leukemia (AML) with t(6;11)(q27;q23) is a well established but rare entity, and few studies have reported the full clinical, hematologic, and outcome data of patients with this disease. ## METHODS To characterize the features of t(6;11) AML, the authors se

Risk- and response-based classification

Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG)

✍ Schultz, K. R.; Pullen, D. J.; Sather, H. N.; Shuster, J. J.; Devidas, M.; Borow 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 324 KB

An evaluation of combinations of diaziqu

An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B

✍ Lee, E J; George, S L; Amrein, P C; Paciucci, P A; Allen, S L; Schiffer, C A 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 58 KB